Pathophysiology of Type 2 Diabetes Mellitus

1. Overview: The Core Defects

• Decreased biological response of peripheral tissues to insulin (insulin resistance)
• Relative - then eventually absolute - insulin deficiency from progressive β-cell failure

• Tietz Textbook of Laboratory Medicine, 7e, p. 1730

2. Insulin Resistance

Definition

Mechanisms

• Visceral/central obesity leads to elevated circulating FFAs
• FFAs impair insulin signaling in muscle and liver (lipotoxicity)
• They activate serine kinases (e.g., IKKβ, JNK) that phosphorylate insulin receptor substrate (IRS-1) at serine residues, blocking the normal tyrosine phosphorylation signal cascade
• Reduced translocation of GLUT4 to the cell surface in skeletal muscle limits glucose uptake

• Visceral adipose tissue becomes infiltrated by macrophages
• Elevated pro-inflammatory cytokines - TNF-α and IL-6 - impair insulin receptor signaling
• This systemic inflammation is a key pathologic link between obesity and T2DM
• Tietz Textbook of Laboratory Medicine, 7e, p. 1730

• Leptin resistance occurs with obesity
• Adiponectin (an insulin-sensitizing adipokine) is reduced in obesity and T2DM
• This imbalance worsens insulin resistance further

Metabolic Syndrome / Syndrome X

• Tietz Textbook of Laboratory Medicine, 7e, p. 1730

3. β-Cell Dysfunction and Failure

Early Phase: Compensation

Progressive Failure: Key Mechanisms

• Chronic hyperglycemia renders β-cells increasingly unresponsive to glucose stimulation - termed selective glucose unresponsiveness
• The degree of β-cell dysfunction correlates with both glucose concentration and duration of hyperglycemia
• Restoration of euglycemia can rapidly reverse this defect

• Elevated circulating FFAs directly impair β-cell function
• This is a major cause of β-cell failure in the setting of obesity and T2DM
• Tietz Textbook of Laboratory Medicine, 7e, p. 1730

• Glucotoxicity and lipotoxicity trigger β-cell apoptosis
• Fatty acids, lipoproteins, leptin, and cytokines (all elevated in obesity/T2DM) accelerate β-cell death
• The total β-cell mass is reduced in T2DM patients
• Mulholland and Greenfield's Surgery, 7e

• Oxidative stress and endoplasmic reticulum (ER) stress may cause β-cells to dedifferentiate (lose β-cell identity) rather than die outright
• Stressed β-cells downregulate β-cell-specific genes including the proinsulin-processing enzyme, explaining the increased proinsulin-to-insulin ratio seen in T2DM
• Mulholland and Greenfield's Surgery, 7e, p. 1891

• Normal pulsatile insulin release is lost
• First-phase insulin secretion (the rapid spike in response to a glucose load) is blunted or absent - this is one of the earliest detectable defects
• Increased proinsulin:insulin ratio in plasma

• Amyloid deposits derived from islet amyloid polypeptide (IAPP/amylin) accumulate in islets of T2DM patients
• IAPP co-secreted with insulin; its aggregation forms toxic oligomers that further impair β-cell function

4. Role of Other Organs: The "Ominous Octet"

5. Genetic Factors

• T2DM is polygenic. Susceptibility genes include those for β-cell function (TCF7L2 - the strongest genetic risk factor), insulin signaling (PPARG, KCNJ11), and cell development
• Concordance in identical twins is ~70-80%, indicating strong genetic predisposition
• Mutations in IRS-1 (insulin receptor substrate) and INSR (insulin receptor) cause severe insulin resistance
• Mulholland and Greenfield's Surgery, 7e

6. Environmental and Lifestyle Factors

• Obesity is the single most important modifiable risk factor. 60-80% of T2DM patients are obese, though diabetes develops in <15% of obese individuals, emphasizing the need for genetic predisposition
• Physical inactivity reduces GLUT4 expression and insulin sensitivity in muscle
• Diet - high caloric intake, refined carbohydrates, saturated fats promote insulin resistance
• Duration and distribution of fat matter: visceral (central) fat is far more metabolically harmful than subcutaneous fat
• Rising global prevalence of T2DM is closely tracked with rising obesity rates
• Tietz Textbook of Laboratory Medicine, 7e, p. 1730

7. Disease Progression: From Prediabetes to Overt T2DM

Normal glucose tolerance
        ↓
Insulin resistance (compensated - euglycemia maintained by hyperinsulinemia)
        ↓
Impaired Fasting Glucose / Impaired Glucose Tolerance (Prediabetes)
        ↓
Overt T2DM (β-cell failure → relative insulin deficiency)
        ↓
Late T2DM (absolute insulin deficiency → may require insulin)

8. Glucose Toxicity as a Vicious Cycle

• Glucotoxicity further impairs β-cell function
• Oxidative stress increases from glucose auto-oxidation
• Advanced glycation end-products (AGEs) form and contribute to microvascular complications
• These changes worsen insulin resistance, closing the vicious cycle
• Tietz Textbook of Laboratory Medicine, 7e
• Mulholland and Greenfield's Surgery, 7e
• Katzung's Basic and Clinical Pharmacology, 16e
• Harrison's Principles of Internal Medicine, 22e (2025)